Donor memory-like NK cells persist and induce remissions in pediatric patients with relapsed AML after transplant

氟达拉滨 医学 阿糖胞苷 髓系白血病 供者淋巴细胞输注 免疫学 白血病 移植 造血干细胞移植 髓样 淋巴细胞 醛类白血病 内科学 化疗 免疫系统 白细胞介素2 环磷酰胺
作者
Jeffrey J. Bednarski,Clare Zimmerman,Melissa M. Berrien-Elliott,Jennifer Ann Foltz,Michelle Becker‐Hapak,Carly C. Neal,Mark Foster,Timothy Schappe,Ethan D. McClain,Patrick Pence,Sweta Desai,Samantha Kersting-Schadek,Pamela Wong,David A. Russler‐Germain,Bryan A. Fisk,Wen‐Rong Lie,Jeremy Eisele,Stephanie Hyde,Sima T. Bhatt,Obi L. Griffith
出处
期刊:Blood [Elsevier BV]
卷期号:139 (11): 1670-1683 被引量:174
标识
DOI:10.1182/blood.2021013972
摘要

Pediatric and young adult (YA) patients with acute myeloid leukemia (AML) who relapse after allogeneic hematopoietic cell transplantation (HCT) have an extremely poor prognosis. Standard salvage chemotherapy and donor lymphocyte infusions (DLIs) have little curative potential. Previous studies showed that natural killer (NK) cells can be stimulated ex vivo with interleukin-12 (IL-12), -15, and -18 to generate memory-like (ML) NK cells with enhanced antileukemia responses. We treated 9 pediatric/YA patients with post-HCT relapsed AML with donor ML NK cells in a phase 1 trial. Patients received fludarabine, cytarabine, and filgrastim followed 2 weeks later by infusion of donor lymphocytes and ML NK cells from the original HCT donor. ML NK cells were successfully generated from haploidentical and matched-related and -unrelated donors. After infusion, donor-derived ML NK cells expanded and maintained an ML multidimensional mass cytometry phenotype for >3 months. Furthermore, ML NK cells exhibited persistent functional responses as evidenced by leukemia-triggered interferon-γ production. After DLI and ML NK cell adoptive transfer, 4 of 8 evaluable patients achieved complete remission at day 28. Two patients maintained a durable remission for >3 months, with 1 patient in remission for >2 years. No significant toxicity was experienced. This study demonstrates that, in a compatible post-HCT immune environment, donor ML NK cells robustly expand and persist with potent antileukemic activity in the absence of exogenous cytokines. ML NK cells in combination with DLI present a novel immunotherapy platform for AML that has relapsed after allogeneic HCT. This trial was registered at https://clinicaltrials.gov as #NCT03068819.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
橘子海完成签到 ,获得积分10
1秒前
梨花发布了新的文献求助10
1秒前
ndbos完成签到 ,获得积分10
2秒前
万能图书馆的应助被香蕉梨愁采纳,获得10
2秒前
cdercder的应助被怡然安梦采纳,获得10
3秒前
3秒前
4秒前
fsdgsd发布了新的文献求助10
5秒前
ppp发布了新的文献求助10
5秒前
52Hz完成签到,获得积分10
7秒前
赘婿的应助被jhlllllll采纳,获得10
7秒前
zhe1e完成签到,获得积分10
7秒前
7秒前
Owen的应助被yutian采纳,获得10
7秒前
zz发布了新的文献求助10
7秒前
8秒前
落日的应助被daomaihu采纳,获得100
8秒前
L77的应助被daomaihu采纳,获得100
9秒前
YunjiangZhang发布了新的文献求助10
9秒前
L77的应助被daomaihu采纳,获得100
9秒前
9秒前
10秒前
10秒前
王一g完成签到,获得积分0
10秒前
赘婿的应助被nmn采纳,获得10
11秒前
11秒前
顾矜的应助被阳光雨堂采纳,获得10
12秒前
英俊的铭的应助被刘智舰采纳,获得10
12秒前
12秒前
www完成签到,获得积分10
12秒前
14秒前
rhy发布了新的文献求助10
14秒前
jjjj佳完成签到,获得积分10
15秒前
15秒前
友好的冰巧完成签到,获得积分10
15秒前
柚岫完成签到,获得积分20
16秒前
16秒前
小小y发布了新的文献求助10
16秒前
ahxb完成签到,获得积分10
17秒前
要减肥平卉完成签到,获得积分10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Markov Decision Processes and Reinforcement Learning 700
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8171039
求助须知:如何正确求助?哪些是违规求助? 9563751
关于积分的说明 21772122
捐赠科研通 7762548
什么是DOI,文献DOI怎么找? 3430786
关于科研通互助平台的介绍 2554676
邀请新用户注册赠送积分活动 2475657